SCHEMBL6945009

SCHEMBL6945009

C#Cc1ccccc1Nc1c(C(=O)NOCC2CC2)cc(F)c(F)c1F

nearest known ligand 0.62

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.62
KMT2A Q03164 1/20 0.62
TDP1 Q9NUW8 1/20 0.62
MAP2K1 Q02750 19/20 0.50
RAF1 P04049 1/20 0.50
PDGFRB P09619 1/20 0.50
CSNK2A2 P19784 1/20 0.50
MAP2K2 P36507 1/20 0.50
CSNK2B P67870 1/20 0.50
CSNK2A1 P68400 1/20 0.50
CSNK2A3 Q8NEV1 1/20 0.50
AURKC Q9UQB9 1/20 0.50
CAMK2A Q9UQM7 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6947497 0.82 MEN1 (0.75) MEN1KMT2ATDP1MAP2K1RAF1
SCHEMBL6944537 0.82 MAP2K1 (0.61) MEN1KMT2ATDP1MAP2K1RAF1
SCHEMBL5400466 0.79 MEN1 (0.83) MEN1KMT2ATDP1MAP2K1RAF1
SCHEMBL24472623 0.78 MEN1 (0.82) MEN1KMT2ATDP1MAP2K1RAF1
SCHEMBL5389144 0.77 MEN1 (0.79) MEN1KMT2ATDP1MAP2K1RAF1
SCHEMBL5389799 0.77 MAP2K1 (0.82) MEN1KMT2ATDP1MAP2K1RAF1
SCHEMBL1801637 0.77 MEN1 (1.00) MEN1KMT2ATDP1MAP2K1RAF1
SCHEMBL29356577 0.77 MEN1 (1.00) MEN1KMT2ATDP1MAP2K1RAF1
SCHEMBL6950462 0.75 MEN1 (0.76) MEN1KMT2ATDP1MAP2K1RAF1
SCHEMBL6947451 0.74 MEN1 (0.75) MEN1KMT2ATDP1MAP2K1RAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202724-B1 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER LAMBERT CO (US) 2003-10-01 EP claimed